Valentina Cannone Selected Research

Natriuretic Peptides

1/2024	MANP in Hypertension With Metabolic Syndrome: Proof-of-Concept Study of Natriuretic Peptide-Based Therapy for Cardiometabolic Disease.
1/2023	EVIDENCE FOR ANGIOTENSIN II AS A NATURALLY EXISTING SUPPRESSOR FOR THE NATRIURETIC PEPTIDE SYSTEM.
1/2023	Natriuretic peptide pathways in heart failure: further therapeutic possibilities.
1/2021	Natriuretic Peptides and Blood Pressure Homeostasis: Implications for MANP, a Novel Guanylyl Cyclase a Receptor Activator for Hypertension.
9/2017	Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis).
1/2015	Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.
10/2014	The Anp genetic variant Rs5068 and circulating levels of natriuretic peptides in patients with chronic heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valentina Cannone Research Topics

Disease

12	Hypertension (High Blood Pressure) 01/2024 - 04/2011
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024 - 08/2011
7	Heart Failure 01/2023 - 12/2011
6	Obesity 01/2023 - 08/2011
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 11/2013
4	Metabolic Diseases (Metabolic Disease) 07/2019 - 01/2015
2	Insulin Resistance 01/2024 - 07/2019
2	Atherosclerosis 10/2019 - 09/2017
2	Chronic Renal Insufficiency 12/2015 - 01/2015
2	Abdominal Obesity 12/2015 - 01/2015
1	Renal Insufficiency (Renal Failure) 01/2022
1	Essential Hypertension 01/2021
1	Eclampsia 05/2020
1	Edema (Dropsy) 05/2020
1	Breast Neoplasms (Breast Cancer) 05/2020
1	Ascites 05/2020
1	Neoplasm Metastasis (Metastasis) 05/2020
1	Abdominal Pain (Pain, Abdominal) 05/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2020
1	Posterior Leukoencephalopathy Syndrome 05/2020
1	Hyperphosphatemia 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Hyperkalemia 01/2020
1	Hypocalcemia 01/2020
1	Hyponatremia 01/2020
1	Inappropriate ADH Syndrome (SIADH) 01/2020
1	Headache (Headaches) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Paraganglioma (Paragangliomas) 01/2020
1	Pheochromocytoma 01/2020
1	Polycythemia (Erythrocytosis) 01/2020
1	Proteinuria 01/2020
1	Fatigue 01/2020
1	Tumor Lysis Syndrome 01/2020
1	Inflammation (Inflammations) 01/2017
1	Type 2 Diabetes Mellitus (MODY) 12/2015
1	Atrial Fibrillation 01/2015
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2015
1	Stroke (Strokes) 12/2011
1	Myocardial Infarction 08/2011

Drug/Important Bio-Agent (IBA)

11	Atrial Natriuretic Factor (ANF)IBA 01/2024 - 08/2011
7	Natriuretic PeptidesIBA 01/2024 - 10/2014
5	AldosteroneIBA 01/2021 - 01/2015
4	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2019 - 12/2011
3	pro-brain natriuretic peptide (1-76)IBA 10/2019 - 12/2011
3	HDL CholesterolIBA 01/2017 - 08/2011
2	atrial natriuretic factor receptor AIBA 01/2024 - 01/2021
2	CreatinineIBA 01/2023 - 01/2022
2	SodiumIBA 01/2022 - 01/2020
2	Vasopressins (Vasopressin)IBA 01/2022 - 01/2020
2	Peptides (Polypeptides)IBA 01/2021 - 04/2011
2	MagnesiumIBA 05/2020 - 01/2020
2	LipidsIBA 07/2019 - 12/2015
2	Triglycerides (Triacylglycerol)IBA 01/2017 - 01/2015
1	Insulin (Novolin)FDA Link 01/2023
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2023
1	Tolvaptan FDA Link 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2022
1	Hormones (Hormone)IBA 01/2021
1	Estrogen Receptor AntagonistsIBA 05/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2020
1	Fulvestrant (Faslodex)FDA Link 05/2020
1	Bevacizumab (Avastin)FDA Link 05/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020
1	palbociclibIBA 05/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	CalciumIBA 01/2020
1	Erythropoietin FDA Link 01/2020
1	Platinum Compounds (Compounds, Platinum)IBA 01/2020
1	EnzymesIBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Alkylating AgentsIBA 01/2020
1	ElectrolytesIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Phosphates (Orthophosphate)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	PotassiumIBA 01/2020
1	Chromogranin AIBA 01/2020
1	Vinca AlkaloidsIBA 01/2020
1	Cyclic GMPIBA 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 01/2018
1	cenderitideIBA 01/2018
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2018
1	HDL LipoproteinsIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	C-Reactive ProteinIBA 08/2011

Therapy/Procedure

6	Therapeutics 06/2021 - 09/2013
2	Drug Therapy (Chemotherapy) 05/2020 - 01/2020
1	Subcutaneous Injections 01/2024
1	Genomic Medicine 01/2021
1	Radiotherapy 05/2020
1	Adrenalectomy 01/2020